Intuniv(guanfacine extended-release tablets)is a central α2A receptor agonist.Before medication,cardiovascular disease history and allergy histor...
Guanfacine extended-release tablets exert their therapeutic effect through central α2A receptor agonism.During treatment,key precautions must be ...
Common side effects of guanfacine extended-release tablets are mainly drowsiness,headache,and decreased appetite,most of which are related to the...
Intuniv(guanfacine extended-release tablets)is an α2A adrenergic receptor agonist used for attention-deficit/hyperactivity disorder(ADHD).Its adm...
Pemafibrate is generally well tolerated, but some patients may experience nausea, abdominal bloating, or rash. Most reactions are mild and can be...
Pemafibrate is used for hypertriglyceridemia. During treatment, it is important to focus on monitoring liver- and muscle-related adverse reaction...
Although Pemafibrate is a selective PPARα modulator, it is not suitable for all patients with dyslipidemia. Patients with severe hepatic impairme...
Pemafibrate is a selective PPARα modulator mainly used to treat hypertriglyceridemia. Correct administration is key to ensuring efficacy and redu...
During azacitidine treatment, must be emphasized; standardized monitoring and timely management are key to safe medication use. I. Myelosuppre...
Azacitidine is used in the treatment of myelodysplastic syndromes and other conditions, but patients with severe liver injury, pregnant women, an...